Funding boost for type 1 diabetes research

Media-Newswire

A new treatment for type 1 diabetes could be a step closer thanks to a EU grant of €10.9 million.

Two University of Bristol academics are part of a group of 14 leading researchers who have received the award. Professor Polly Bingley and Dr Colin Dayan will collaborate with researchers from eight European countries to develop and trial "natural immunomodulators" to change the immune process that destroys the insulin making cells in this condition.

Type 1 diabetes, formerly known as juvenile onset diabetes, affects over 100,000 adults and children in the UK and results in a life-long dependence on insulin injections.

Professor Bingley's research group have shown that children who are going to develop type 1 diabetes can be identified many years in advance by testing for particular antibodies in their blood.

Read MORE.